Cell and Gene Outsourcing
-
Engineering Rep-Cap Plasmids To Enhance AAV Manufacturability, Potency
6/2/2025
Discover how our engineered Rep-Cap plasmids dramatically enhance AAV vector yield, quality, and scalability, offering a powerful, next-generation solution to overcome manufacturing challenges.
-
Operator Training Programs
5/29/2025
Build a stronger biomanufacturing workforce with flexible, expert-led operator training. Empower your team with essential process knowledge, technology insights, and hands-on equipment skills anytime, anywhere, and at their own pace.
-
Clues To Mapping A Crisis-Ready Tech Transfer Playbook
5/28/2025
One of the many people behind AstraZeneca's COVID-19 response describes lessons learned during the biggest global health emergency of the modern era.
-
Accelerate And Enhance Biomanufacturing Operator Training
5/28/2025
Unlock the power of blended operator training and learn how combining digital tools with hands-on instruction reduces errors, boosts retention, and empowers your workforce for real-world production success.
-
Advancing Lentiviral Vector Manufacturing: A Platform For Commercial Cell Therapy Success
5/28/2025
Explore how the LentiPeak™ platform can accelerate the development and commercialization of LV-based therapies, using GMP manufacturing, scale-down model validation, and a process design approach.
-
Evaluating BACS For T Cell Isolation In CAR-T Manufacturing
5/28/2025
Consider how Buoyancy Activated Cell Sorting (BACS) can streamline T cell isolation, reduce costs, and enhance CAR T and TCR cell therapy manufacturing — access the full study to learn more.
-
CRISPR System Enables CNS Biodistribution, mHTT Protein Reduction
5/28/2025
Discover how a diverse collection of RNA-guided nucleases, base editors, and reverse transcriptase editors with unique PAM recognition sequences can enable flexible and precise genome editing.
-
Driving Innovation And Scalability In Advanced Therapies
5/28/2025
By fostering strong collaborations and maintaining flexibility, BaseCamp is preparing for the complex landscape of commercial manufacturing while prioritizing quality, efficiency, and patient access.
-
Proud To Be Part Of Arm: Advancing The Future Of Regenerative Medicine Together
5/28/2025
With hundreds of members spanning over 25 countries, ARM serves as a hub for innovation, policy development, and cross-sector collaboration in regenerative medicine.
-
Development Of Endothelial-Cord Cell Banks And Blood Stem Cell Products
5/28/2025
Leverage our proven cGMP expertise in cell therapy manufacturing, from primary tissue processing to large-scale production for clinical trials.